Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome

Ann Hematol. 2020 Feb;99(2):381-383. doi: 10.1007/s00277-019-03849-x. Epub 2019 Nov 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow / pathology
  • Cyclophosphamide / administration & dosage
  • Cytokines / analysis
  • Cytokines / biosynthesis*
  • Doxorubicin / administration & dosage
  • Epstein-Barr Virus Infections / complications*
  • Epstein-Barr Virus Infections / metabolism
  • Fatal Outcome
  • Female
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Lymph Nodes / pathology
  • Lymphohistiocytosis, Hemophagocytic / etiology*
  • Lymphohistiocytosis, Hemophagocytic / pathology
  • Lymphoma, Large B-Cell, Diffuse / complications*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Lymphoma, Large B-Cell, Diffuse / virology
  • Middle Aged
  • Neoplastic Stem Cells / chemistry
  • Neoplastic Stem Cells / pathology
  • Neoplastic Stem Cells / virology*
  • Prednisone / administration & dosage
  • RNA, Viral / analysis
  • Rituximab / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Cytokines
  • RNA, Viral
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol